Form 4: Aptevo Therapeutics SVP, CFO Daphne Taylor Reports Stock Transactions
SEC Form 4
Daphne Taylor, SVP and CFO of Aptevo Therapeutics, reports the vesting and conversion of restricted stock units into common stock on March 2 and March 4, 2024.
Summary
- Daphne Taylor, the SVP and CFO of Aptevo Therapeutics Inc., filed a Form 4 detailing changes in beneficial ownership.
- On March 2, 2024, 3,667 Restricted Stock Units (RSUs) vested and were converted into common stock.
- On March 4, 2024, an additional 1,584 RSUs vested and were converted into common stock.
- Following these transactions, Taylor directly owns 18,411 shares of Aptevo Therapeutics common stock and 1,583 RSUs.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders and their holdings in the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increase in outstanding shares, but the effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| June 7, 2022 | Reporting person was granted 4,750 RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023. |
| March 3, 2023 | The reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024. |
| March 2, 2024 | 3,667 RSUs vested and converted into common stock. |
| March 4, 2024 | 1,584 RSUs vested and converted into common stock. |
| March 5, 2024 | Date of signature for the Form 4 filing. |
Keywords
Aptevo Therapeutics, Daphne Taylor, Form 4, Beneficial Ownership, Restricted Stock Units, RSUs, Common Stock, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.